Therapeutic combinations of antihypertensive and antiangiogenic agents

Details for Australian Patent Application No. 2001244386 (hide)

Owner AstraZeneca AB

Inventors Ogilvie, Donald James; Curwen, Jon Owen

Agent Davies Collison Cave

Pub. Number AU-B-2001244386

PCT Pub. Number WO01/74360

Priority 0008269 05.04.00 GB

Filing date 2 April 2001

Wipo publication date 15 October 2001

Acceptance publication date 27 January 2005

International Classifications

A61K 031/505 - Pyrimidines

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61P 037/00 Drugs for immunological or allergic disorders

A61P 035/00 Antineoplastic agents

A61P 027/00 Drugs for disorders of the senses

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 017/06 Drugs for dermatological disorders

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 005/50 Drugs for disorders of the endocrine system

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

27 January 2005 Application Accepted

  Published as AU-B-2001244386

26 May 2005 Standard Patent Sealed

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001244388

2001244381